Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 15.77% is 10% below its 5-year average of 17.55%, near the low end of its 5-year range (13.63%–21.66%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.51% above its 12-month average of 15.54%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
15.77%
EBITDA MARGIN AVG TTM
15.54%
EBITDA MARGIN AVG 3Y
16.95%
EBITDA MARGIN AVG 5Y
17.55%
EBITDA MARGIN AVG 10Y
16.70%
EBITDA MARGIN AVG 15Y
15.56%
EBITDA MARGIN AVG 20Y
14.89%
CURRENT VS TTM AVG
+1.51%
CURRENT VS 3Y AVG
-6.93%
CURRENT VS 5Y AVG
-10.14%
CURRENT VS 10Y AVG
-5.58%
CURRENT VS 15Y AVG
+1.37%
CURRENT VS 20Y AVG
+5.93%
Chemed Corporation
Market Cap
$6.80B
EBITDA Margin
15.77%
TTM Avg
15.54%
3Y Avg
16.95%
5Y Avg
17.55%
Market Cap
$7.06B
EBITDA Margin
6.82%
TTM Avg
6.08%
3Y Avg
-0.44%
5Y Avg
-8.67%
Market Cap
$7.79B
EBITDA Margin
-3.14%
TTM Avg
-1.08%
3Y Avg
-5.02%
5Y Avg
-19.32%
Market Cap
$5.35B
EBITDA Margin
21.06%
TTM Avg
20.50%
3Y Avg
18.63%
5Y Avg
16.67%
Market Cap
$10.11B
EBITDA Margin
10.47%
TTM Avg
10.43%
3Y Avg
10.38%
5Y Avg
10.85%
Market Cap
$10.37B
EBITDA Margin
2.15%
TTM Avg
3.41%
3Y Avg
4.20%
5Y Avg
4.49%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Chemed Corporation (CHE) | $6.80B | 15.77% | 15.54% | 16.95% | 17.55% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.06B | 6.82% | 6.08% | -0.44% | -8.67% |
| Oscar Health, Inc. (OSCR)vs › | $7.79B | -3.14% | -1.08% | -5.02% | -19.32% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.35B | 21.06% | 20.50% | 18.63% | 16.67% |
| Doximity, Inc. (DOCS)vs › | $4.79B | 35.56% | 38.69% | 36.58% | 34.55% |
| Insulet Corp. (PODD)vs › | $9.93B | 21.67% | 20.24% | 16.36% | 15.66% |
| The Ensign Group, Inc. (ENSG)vs › | $10.11B | 10.47% | 10.43% | 10.38% | 10.85% |
| Henry Schein, Inc. (HSIC)vs › | $10.28B | 8.11% | 8.11% | 8.28% | 8.19% |
| Molina Healthcare, Inc. (MOH)vs › | $10.37B | 2.15% | 3.41% | 4.20% | 4.49% |
| TransMedics Group, Inc. (TMDX)vs › | $3.17B | 22.42% | 17.70% | -0.76% | -37.34% |
Gross Margin
30.4%
EBITDA Margin
15.8%
Operating Margin
13.5%
Net Margin
10.6%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 15.77% |
| 2026-03-31 | 15.43% |
| 2025-12-31 | 18.30% |
| 2025-09-30 | 14.56% |
| 2025-06-30 | 13.63% |
| 2025-03-31 | 17.12% |
| 2024-12-31 | 20.27% |
| 2024-09-30 | 17.79% |
| 2024-06-30 | 17.43% |
| 2024-03-31 | 14.96% |
| 2023-12-31 | 21.66% |
| 2023-09-30 | 18.11% |
| 2023-06-30 | 15.29% |
| 2023-03-31 | 15.64% |
| 2022-12-31 | 17.55% |
| 2022-09-30 | 18.15% |
| 2022-06-30 | 20.17% |
| 2022-03-31 | 19.61% |
| 2021-12-31 | 20.77% |
| 2021-09-30 | 19.91% |
| 2021-06-30 | 16.50% |
| 2021-03-31 | 17.95% |
| 2020-12-31 | 29.55% |
| 2020-09-30 | 16.76% |
| 2020-06-30 | 21.29% |
| 2020-03-31 | 18.07% |
| 2019-12-31 | 17.53% |
| 2019-09-30 | 15.71% |
| 2019-06-30 | 16.01% |
| 2019-03-31 | 12.92% |
| 2018-12-31 | 16.94% |
| 2018-09-30 | 16.08% |
| 2018-06-30 | 15.37% |
| 2018-03-31 | 14.96% |
| 2017-12-31 | 15.29% |
| 2017-09-30 | 15.06% |
| 2017-06-30 | -7.25% |
| 2017-03-31 | 12.42% |
| 2016-12-31 | 15.33% |
| 2016-09-30 | 13.14% |
| 2016-06-30 | 12.05% |
| 2016-03-31 | 13.55% |
| 2015-12-31 | 14.19% |
| 2015-09-30 | 15.11% |
| 2015-06-30 | 13.83% |
| 2015-03-31 | 12.94% |
| 2014-12-31 | 15.49% |
| 2014-09-30 | 13.50% |
| 2014-06-30 | 13.75% |
| 2014-03-31 | 12.51% |
| 2013-12-31 | 13.67% |
| 2013-09-30 | 10.96% |
| 2013-06-30 | 9.51% |
| 2013-03-31 | 12.76% |
| 2012-12-31 | 14.63% |
| 2012-09-30 | 12.32% |
| 2012-06-30 | 13.28% |
| 2012-03-31 | 11.99% |
| 2011-12-31 | 15.22% |
| 2011-09-30 | 14.28% |
| 2011-06-30 | 13.00% |
| 2011-03-31 | 11.42% |
| 2010-12-31 | 13.61% |
| 2010-09-30 | 13.84% |
| 2010-06-30 | 13.12% |
| 2010-03-31 | 13.32% |
| 2009-12-31 | 12.53% |
| 2009-09-30 | 13.40% |
| 2009-06-30 | 11.82% |
| 2009-03-31 | 14.10% |
| 2008-12-31 | 15.51% |
| 2008-09-30 | 14.60% |
| 2008-06-30 | 12.79% |
| 2008-03-31 | 12.88% |
| 2007-12-31 | 13.80% |
| 2007-09-30 | 13.69% |
| 2007-06-30 | 13.59% |
| 2007-03-31 | 13.21% |
| 2006-12-31 | 16.04% |
| 2006-09-30 | 9.56% |
| 2006-06-30 | 12.31% |
| 2006-03-31 | 12.43% |
| 2005-12-31 | 6.66% |
| 2005-09-30 | 12.96% |
| 2005-06-30 | 12.22% |
| 2005-03-31 | 12.94% |
| 2004-12-31 | 12.02% |
| 2004-09-30 | 12.29% |
| 2004-06-30 | 12.70% |
| 2004-03-31 | 3.89% |
| 2003-12-31 | -16.25% |
| 2003-09-30 | 7.36% |
| 2003-06-30 | 7.72% |
| 2003-03-31 | 5.25% |
| 2002-12-31 | -17.45% |
| 2002-09-30 | 12.38% |
